The Global Enteral Feeding Formulas Market is Trending by Convenience and Portability

The Global Enteral Feeding Formulas Market is estimated to be valued at US$ 5.79 BN in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period of 2024 to 2031.

The global enteral feeding formulas market provides nutrition through oral or tube feeding to patients who cannot consume food or absorb sufficient nutrients from their diet. Enteral feeding formulas help to prevent malnutrition in chronic disease conditions such as cancer, gastrointestinal disorders, and neurological disorders. Standard formulas provide balanced nutrition containing proteins, carbohydrates, fats, vitamins, and minerals vital for growth and development. Formula types include powder, liquid, and ready-to-use. The formulas are customizable based on a patient's condition and administered via feeding pumps or feeding tubes.

Key Takeaways

Key players operating in the global enteral feeding formulas market are Abbott, Danone S.A., Fresenius Kabi AG, Nestle, Meiji Holdings, and Mead Johnson & Company, LLC. Key players are focusing on new product launches catering to preference for convenience and portability. The rising prevalence of chronic diseases and growing elderly population are driving demand for enteral feeding formulas globally. Moreover, increasing awareness regarding nutritional support in healthcare and expanding availability of formulas through online sales channels are favoring market growth.

Market Key Trends

One of the key trends in the Enteral Feeding Formulas Market Size is the preference for convenient and portable products. Key players are introducing easy-to-carry and on-the-go formulas to cater to active lifestyles. For instance, ready-to-drink liquid and bottled formulas do not require mixing with water. Similarly, powder formulas are available in single-serve sachets for enhanced convenience. Another notable trend is the rising demand for specialized and clinical nutrition formulas. With increasing chronic diseases, the demand is growing for formulas tailored to specific conditions like diabetes, renal disorders, and congenital metabolic disorders. Players are focusing on specialized R&D to offer condition-specific formulations.

Porter's Analysis

Threat of new entrants: Entry barriers are moderate due to significant capital requirement for manufacturing and distribution network. However, the market growth gives opportunities.

Bargaining power of buyers: Buyers have modest bargaining power due to availability of substitutes, but lack of standardized products increase dependence on major players.

Bargaining power of suppliers: Suppliers of raw materials have low to moderate bargaining power as large players can source materials from multiple suppliers.

Threat of new substitutes: Threat from substitutes is moderate as new delivery modes are emerging but acceptance take time given critical nature.

Competitive rivalry: Rivalry is high among the major multinational players resulting in aggressive pricing, promotion and differentiating strategies to gain market share.

Geographical Regions

North America holds the largest share in the global enteral feeding formulas market currently, due to higher incidences of chronic diseases like cancer and growing aging population. However, Asia Pacific region is expected to witness the fastest growth during the forecast period, supported by improving reimbursement scenario and rising adoption of tube feeding in China and India.

Get more insights on Enteral Feeding Formulas Market


snehacmi01

282 Blog posts

Comments